Logo image of LFST

LIFESTANCE HEALTH GROUP INC (LFST) Stock Fundamental Analysis

USA - NASDAQ:LFST - US53228F1012 - Common Stock

5.23 USD
-0.14 (-2.61%)
Last: 9/19/2025, 8:26:00 PM
5.23 USD
0 (0%)
After Hours: 9/19/2025, 8:26:00 PM
Fundamental Rating

3

Overall LFST gets a fundamental rating of 3 out of 10. We evaluated LFST against 101 industry peers in the Health Care Providers & Services industry. The financial health of LFST is average, but there are quite some concerns on its profitability. LFST is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LFST had negative earnings in the past year.
In the past year LFST had a positive cash flow from operations.
In the past 5 years LFST always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LFST reported negative operating cash flow in multiple years.
LFST Yearly Net Income VS EBIT VS OCF VS FCFLFST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

LFST has a Return On Assets (-0.75%) which is comparable to the rest of the industry.
LFST has a Return On Equity of -1.10%. This is comparable to the rest of the industry: LFST outperforms 51.49% of its industry peers.
Industry RankSector Rank
ROA -0.75%
ROE -1.1%
ROIC N/A
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
LFST Yearly ROA, ROE, ROICLFST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LFST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LFST Yearly Profit, Operating, Gross MarginsLFST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

More info and screens

5

2. Health

2.1 Basic Checks

LFST does not have a ROIC to compare to the WACC, probably because it is not profitable.
LFST has more shares outstanding than it did 1 year ago.
LFST has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LFST has a worse debt to assets ratio.
LFST Yearly Shares OutstandingLFST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
LFST Yearly Total Debt VS Total AssetsLFST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.96 indicates that LFST is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.96, LFST perfoms like the industry average, outperforming 46.53% of the companies in the same industry.
The Debt to FCF ratio of LFST is 2.36, which is a good value as it means it would take LFST, 2.36 years of fcf income to pay off all of its debts.
LFST has a Debt to FCF ratio of 2.36. This is amongst the best in the industry. LFST outperforms 82.18% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that LFST is not too dependend on debt financing.
LFST has a Debt to Equity ratio of 0.19. This is in the better half of the industry: LFST outperforms 70.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 2.36
Altman-Z 1.96
ROIC/WACCN/A
WACC8.95%
LFST Yearly LT Debt VS Equity VS FCFLFST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.48 indicates that LFST should not have too much problems paying its short term obligations.
LFST has a Current ratio of 1.48. This is comparable to the rest of the industry: LFST outperforms 47.52% of its industry peers.
LFST has a Quick Ratio of 1.48. This is a normal value and indicates that LFST is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.48, LFST is in line with its industry, outperforming 54.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
LFST Yearly Current Assets VS Current LiabilitesLFST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.80% over the past year.
LFST shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.86%.
The Revenue has been growing by 42.55% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)87.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
Revenue 1Y (TTM)13.86%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%10.56%

3.2 Future

LFST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.75% yearly.
Based on estimates for the next years, LFST will show a quite strong growth in Revenue. The Revenue will grow by 12.39% on average per year.
EPS Next Y84.86%
EPS Next 2Y51.34%
EPS Next 3Y46.75%
EPS Next 5YN/A
Revenue Next Year14.17%
Revenue Next 2Y14.23%
Revenue Next 3Y14.52%
Revenue Next 5Y12.39%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LFST Yearly Revenue VS EstimatesLFST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
LFST Yearly EPS VS EstimatesLFST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

LFST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 112.54, which means the current valuation is very expensive for LFST.
61.39% of the companies in the same industry are cheaper than LFST, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.86. LFST is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 112.54
LFST Price Earnings VS Forward Price EarningsLFST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100

4.2 Price Multiples

LFST's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LFST indicates a somewhat cheap valuation: LFST is cheaper than 71.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.94
EV/EBITDA 37.04
LFST Per share dataLFST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

LFST's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LFST's earnings are expected to grow with 46.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.34%
EPS Next 3Y46.75%

More info and screens

0

5. Dividend

5.1 Amount

LFST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFESTANCE HEALTH GROUP INC

NASDAQ:LFST (9/19/2025, 8:26:00 PM)

After market: 5.23 0 (0%)

5.23

-0.14 (-2.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners36.59%
Inst Owner Change1.58%
Ins Owners2.98%
Ins Owner Change-8.61%
Market Cap2.03B
Analysts84
Price Target8.6 (64.44%)
Short Float %4.95%
Short Ratio2.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.66%
Min EPS beat(2)67.32%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)70.6%
Min EPS beat(4)43.98%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)24.17%
EPS beat(12)9
Avg EPS beat(12)15.58%
EPS beat(16)9
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)-1.93%
Revenue beat(4)2
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)1.72%
Revenue beat(8)4
Avg Revenue beat(8)0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.34%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)1.4%
PT rev (3m)-3.28%
EPS NQ rev (1m)16.7%
EPS NQ rev (3m)16.7%
EPS NY rev (1m)0%
EPS NY rev (3m)51.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 112.54
P/S 1.55
P/FCF 16.94
P/OCF 13.88
P/B 1.38
P/tB N/A
EV/EBITDA 37.04
EPS(TTM)-0.05
EYN/A
EPS(NY)0.05
Fwd EY0.89%
FCF(TTM)0.31
FCFY5.9%
OCF(TTM)0.38
OCFY7.21%
SpS3.38
BVpS3.79
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.75%
ROE -1.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 9.12%
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 2.36
Debt/EBITDA 4.75
Cap/Depr 45.9%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion 255.02%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 1.96
F-Score7
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)65.1%
Cap/Depr(5y)98.49%
Cap/Sales(3y)4.93%
Cap/Sales(5y)7.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
EPS Next Y84.86%
EPS Next 2Y51.34%
EPS Next 3Y46.75%
EPS Next 5YN/A
Revenue 1Y (TTM)13.86%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%10.56%
Revenue Next Year14.17%
Revenue Next 2Y14.23%
Revenue Next 3Y14.52%
Revenue Next 5Y12.39%
EBIT growth 1Y99.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year426.23%
EBIT Next 3Y94.79%
EBIT Next 5YN/A
FCF growth 1Y1147.77%
FCF growth 3YN/A
FCF growth 5Y99.09%
OCF growth 1Y339.74%
OCF growth 3Y124.97%
OCF growth 5Y44.46%